Items 221 to 230 of 233 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Integracin A | 224186-03-2 | sc-362026 | 1 mg | $250.00 | 1 | |
Integracin A is a rare and high-purity acid halide distinguished by its exceptional reactivity and selectivity in nucleophilic acyl substitution reactions. Its unique steric configuration allows for precise molecular interactions, enhancing its ability to form stable intermediates. The compound exhibits remarkable stability under various conditions, while its high affinity for specific nucleophiles enables efficient reaction kinetics. These characteristics make Integracin A a versatile candidate for innovative synthetic strategies. | ||||||
Integracin B | 224186-05-4 | sc-362027 | 1 mg | $250.00 | 1 | |
Integracin B is a rare and high-purity acid halide known for its distinctive electrophilic properties and unique reactivity profiles. Its molecular structure facilitates strong interactions with a variety of nucleophiles, leading to rapid reaction kinetics. The compound's ability to stabilize transition states enhances its efficiency in synthetic pathways. Additionally, Integracin B demonstrates remarkable solubility in diverse solvents, further broadening its applicability in complex chemical transformations. | ||||||
Decatromicin B | 235097-64-0 | sc-391512 | 0.5 mg | $315.00 | ||
Decatromicin B is a rare and high-purity acid halide characterized by its exceptional reactivity and selectivity in chemical transformations. Its unique structural features promote specific interactions with electron-rich species, resulting in tailored reaction pathways. The compound exhibits a high degree of stability under various conditions, allowing for controlled manipulation in synthetic processes. Furthermore, Decatromicin B's distinctive physical properties contribute to its versatility in diverse chemical environments. | ||||||
Epiequisetin | 255377-45-8 | sc-391529 | 1 mg | $315.00 | ||
Epiequisetin is a rare and high-purity acid halide distinguished by its remarkable electrophilic nature, facilitating rapid acylation reactions with nucleophiles. Its unique steric configuration enhances selectivity, allowing for precise targeting of functional groups in complex substrates. The compound's high solubility in organic solvents and low viscosity contribute to its efficient mixing and reaction kinetics, making it an intriguing candidate for innovative synthetic methodologies. | ||||||
Antibiotic TS 155-2 | 303009-07-6 | sc-362015 | 1 mg | $250.00 | ||
Antibiotic TS 155-2 is a rare and high-purity acid halide characterized by its exceptional reactivity and specificity in chemical transformations. Its unique electronic structure promotes strong interactions with nucleophiles, leading to selective acylation pathways. The compound exhibits notable stability under various conditions, while its low molecular weight enhances diffusion rates in reaction media. These properties make it a compelling subject for advanced synthetic applications and mechanistic studies. | ||||||
Epicoccamide | 606139-26-8 | sc-391530 | 1 mg | $255.00 | ||
Epicoccamide is a rare and high-purity acid halide distinguished by its intricate molecular interactions and unique reactivity profile. Its structure facilitates rapid electrophilic attack, enabling efficient acyl transfer reactions. The compound's distinctive steric and electronic properties contribute to its selectivity in forming stable intermediates. Additionally, its solubility characteristics allow for enhanced accessibility in diverse reaction environments, making it an intriguing candidate for exploring novel synthetic methodologies. | ||||||
Quinolactacin A1 | 815576-68-2 | sc-391721 | 1 mg | $376.00 | ||
Quinolactacin A1 is a rare and high-purity acid halide characterized by its exceptional reactivity and unique molecular architecture. Its ability to engage in selective nucleophilic substitutions is enhanced by specific steric hindrances, which influence reaction kinetics. The compound exhibits remarkable stability in various solvents, promoting diverse reaction pathways. Its distinct electronic properties facilitate the formation of reactive intermediates, making it a compelling subject for advanced synthetic exploration. | ||||||
Umirolimus | 851536-75-9 | sc-391515 sc-391515A | 1 mg 10 mg | $100.00 $500.00 | ||
Umirolimus is a rare and high-purity acid halide distinguished by its intricate molecular structure and unique electronic characteristics. It demonstrates a propensity for forming stable complexes with transition metals, which can alter its reactivity profile. The compound's specific functional groups enable it to participate in diverse electrophilic reactions, while its low steric hindrance allows for rapid reaction kinetics. This behavior opens avenues for innovative synthetic methodologies and complex molecular assemblies. | ||||||
Antibiotic Sch 725674 | 877061-66-0 | sc-362014 | 1 mg | $250.00 | ||
Antibiotic Sch 725674 is a rare and high-purity acid halide characterized by its exceptional reactivity and selective interaction with nucleophiles. Its unique electronic configuration facilitates the formation of transient intermediates, enhancing its role in catalytic cycles. The compound exhibits distinctive solubility properties, allowing for efficient phase transfer in reactions. Additionally, its ability to stabilize reactive species contributes to its potential in developing novel synthetic pathways and intricate molecular architectures. | ||||||
Lachnone A | 903892-99-9 | sc-391616 | 0.5 mg | $250.00 | ||
Lachnone A is a rare and high-purity acid halide distinguished by its unique steric and electronic properties, which promote selective reactivity with various substrates. Its ability to form stable adducts with nucleophiles is enhanced by specific orbital interactions, leading to distinct reaction kinetics. The compound's solvation dynamics further influence its reactivity profile, enabling it to participate in complex reaction mechanisms and facilitating the synthesis of intricate molecular frameworks. | ||||||